Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis
Author:
Publisher
Elsevier BV
Subject
General Medicine,Immunology and Allergy
Reference7 articles.
1. Eosinophilic myocarditis: characteristics, treatment, and outcomes;Brambatti;J Am Coll Cardiol,2017
2. A review of DRESS-associated myocarditis;Bourgeois;J Am Acad Dermatol,2012
3. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis;Wechsler;N Engl J Med,2017
4. Long-term clinical outcomes of high-dose mepolizumab treatment for hypereosinophilic syndrome;Kuang;J Allergy Clin Immunol Pract,2018
5. Decrease in MPO-ANCA after administration of benralizumab in eosinophilic granulomatosis with polyangiitis;Takenaka;Allergol Int,2019
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rapid effect of benralizumab in fulminant eosinophilic myocarditis in the setting of uncontrolled eosinophilic asthma;Journal of Cardiology Cases;2023-09
2. New therapeutic approaches with biological drugs for eosinophilic granulomatosis with polyangiitis;Exploration of Asthma & Allergy;2023-06-08
3. The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review;Rheumatology International;2023-04-21
4. Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems;Frontiers in Pharmacology;2023-01-16
5. Benralizumab in the management of rare primary eosinophilic lung diseases;Allergy and Asthma Proceedings;2022-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3